In our study, our focus was to investigate the molecular interactions between myricetin and key regulators implicated in diabetes, including glycogen synthase kinase 3 beta (GSK3β), insulin receptor (IR), and glucose kinase (GCK). Here, GCK is linked to diabetes mellitus.